Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
levaxin tafla 0,05 mg
orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,05 mg
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
levaxin tafla 0,1 mg
orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,1 mg
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
nitroglycerin dak tungurótartafla 0,25 mg
orifarm healthcare a/s - glyceryl trinitrate - tungurótartafla - 0,25 mg
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
nitroglycerin dak tungurótartafla 0,5 mg
orifarm healthcare a/s - glyceryl trinitrate - tungurótartafla - 0,5 mg
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
otrivin junior ukonserveret (otrivin ukonserveret) nefúði, lausn 0,5 mg/ml
haleon denmark aps - xylometazolinum hýdróklóríð - nefúði, lausn - 0,5 mg/ml
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
otrivin menthol ukonserveret nefúði, lausn 1 mg/ml
haleon denmark aps - xylometazolinum hýdróklóríð - nefúði, lausn - 1 mg/ml
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
otrivin ukonserveret nefúði, lausn 1 mg/ml
haleon denmark aps - xylometazolinum hýdróklóríð - nefúði, lausn - 1 mg/ml
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
ursochol (ursodiol) hart hylki 250 mg
orifarm generics a/s - acidum ursodeoxycholicum inn - hart hylki - 250 mg
Európska únia -
islandčina -
EMA (European Medicines Agency)
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - bóluefni - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
Island -
islandčina -
LYFJASTOFNUN (Icelandic Medicines Agency)
hyprosan (hypromellose) augndropar, lausn 3,2 mg/ml
santen oy - hypromellosum inn - augndropar, lausn - 3,2 mg/ml